Cardlytics (CDLX) Reports In-Line Q2 EPS
Get Alerts CDLX Hot Sheet
Join SI Premium – FREE
Cardlytics (NASDAQ: CDLX) reported Q2 EPS of ($0.39), in-line with the analyst estimate of ($0.39). Revenue for the quarter came in at $58.9 million versus the consensus estimate of $62.81 million.
GUIDANCE:
Cardlytics sees Q3 2021 revenue of $57-66 million, versus the consensus of $71 million.
For earnings history and earnings-related data on Cardlytics (CDLX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Biogen (BIIB) tops earnings expectations but revenue falls short
- Amphenol (APH) Tops Q1 EPS by 7c, offers guidance
- Blue Foundry Bancorp (BLFY) Tops Q1 EPS by 9c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!